|
QTRX
|
Quanterix Corporation
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VTVT
|
vTv Therapeutics Inc.
|
US
|
NASDAQ
|
|
IVX
|
Invion Ltd
|
AU
|
ASX
|
|
PAR
|
Paradigm Biopharmaceuticals Ltd
|
AU
|
ASX
|
|
ACHFF
|
Arch Biopartners Inc
|
US
|
OTC
|
|
AMGXF
|
Anges Mg Inc
|
US
|
OTC
|
|
ATBPF
|
Antibe Therapeutics
|
US
|
OTC
|
|
ATHJF
|
Antisense Therap Ltd
|
US
|
OTC
|
|
BIOVF
|
Swedish Orphan Biovi
|
US
|
OTC
|
|
BMNDF
|
Biomind Labs Inc
|
US
|
OTC
|
|
CANB
|
Canbiola Inc.
|
US
|
OTC
|
|
CDXI
|
Cardax Inc
|
US
|
OTC
|
|
ENDV
|
Endonovo Therapeutics Inc
|
US
|
OTC
|
|
ETST
|
Earth Science Tech Inc
|
US
|
OTC
|
|
GLAXF
|
GlaxoSmithKline Plc
|
US
|
OTC
|
|
INNPF
|
InnoCan Pharma Corporation
|
US
|
OTC
|
|
IVIXF
|
Invion Ltd
|
US
|
OTC
|